Ambroxol is a medication indicated for airway secretion clearance therapy. Ambroxol is a secretolytic agent used in the treatment of respiratory diseases associated with viscid or …

Viaxol is used to treat certain diseases of the respiratory tract and to relieve cough associated with thickened mucous. Each retard capsule contains Ambroxol hydrochloride 75 mg. Each …

Mar 3, 2020 · Taken together, the clinical evidence for ambroxol shows treatment effects that offer significant benefits to pediatric patients for its licensed use as a secretolytic therapy in acute …

Viaxol drug & pharmaceuticals active ingredients names and forms, pharmaceutical companies. Viaxol indications and usages, prices, online pharmacy health products information.

Marca AMBROXOL Sustancias AMBROXOL Forma Farmacéutica y Formulación Solución Presentación 1 Frasco (s), 30 mL, 7.5 mg/ml 1 Frasco (s), 120 mL, 15/5 mg/ml

Aug 4, 2008 · Background: Belonging to the group of expectorants, ambroxol is an active substance with a long history that influences parameters considered to be the basis for the …

Aumenta la secreción de vías respiratorias, potencia la producción de surfactante pulmonar y estimula la actividad ciliar. Estas acciones tienen como consecuencia una mejoría del flujo y …

Afecciones del tracto respiratorio que cursen con un aumento de la viscosidad de las secreciones bronquiales. Bronquitis aguda o crónica. Traquiectasias, traqueítis. Dosificación. Adultos: …

Jan 1, 2023 · Ambroxol is a commercially available inhibitor of Na v 1.8, a crucial player in the pathophysiology of neuropathic pain, and Na v 1.7, a particularly exciting target for the …

Sustained-Release Capsule:Adults and Children >12 years: 1 cap once daily after meal with plenty of liquid (sufficient supply of liquid supports the expectorant effect of Viaxol).